Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program

BackgroundThe Coronavirus Disease 2019 (COVID-19) pandemic in early 2020 has resulted in an unprecedented level of uncertainty and challenge for the stem cell donor registries. To address these challenges, rapid strategies were implemented by the National Marrow Donor Registry (NMDP) and its network...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Nosha Farhadfar, Jeni Newman, Jennifer Novakovich, Jacklyn Barten, Eric T. Ndifon, Jason Oakes, Meghann Cody, Huy P. Pham, Jeffery J. Auletta, John P. Miller, Steven M. Devine, Heather E. Stefanski
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Subjects:	COVID-19 donor registry unrelated donor hematopoietic stem cells National Marrow Donor Program SARS-CoV-2
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.937900/full